Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Circulation Journal : Official Journal of the Japanese Circulation Society|August 27, 2003
Investigation of the optimal treatment strategy for atrial fibrillation in JapanTakeshi Yamashita, Satoshi Ogawa, Yoshifusa Aizawa, et al.
Circulation. Arrhythmia and Electrophysiology|October 22, 2009
Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3Shiro Kamakura, Tohru Ohe, Kiyoshi Nakazawa, et al.
Journal of the American College of Cardiology|March 22, 2008
Atrial fibrillation in patients with Brugada syndrome relationships of gene mutation, electrophysiology, and clinical backgroundsKengo F Kusano, Makiko Taniyama, Kazufumi Nakamura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|September 26, 2006
Randomized study of angiotensin II type 1 receptor blocker vs dihydropiridine calcium antagonist for the treatment of paroxysmal atrial fibrillation in patients with hypertensionTakeshi Yamashita, Satoshi Ogawa, Yoshifusa Aizawa, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|December 9, 2008
Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM StudySatoshi Ogawa, Takeshi Yamashita, Tsutomu Yamazaki, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|November 5, 2010
SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndromeNobuhiro Nishii, Masahiro Ogawa, Hiroshi Morita, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|December 15, 2010
Randomized trial of angiotensin II-receptor blocker vs. dihydropiridine calcium channel blocker in the treatment of paroxysmal atrial fibrillation with hypertension (J-RHYTHM II study)Takeshi Yamashita, Hiroshi Inoue, Ken Okumura, et al.
Circulation|March 26, 2017
Genotype-Phenotype Correlation of SCN5A Mutation for the Clinical and Electrocardiographic Characteristics of Probands With Brugada Syndrome: A Japanese Multicenter RegistryKenichiro Yamagata, Minoru Horie, Takeshi Aiba, et al.
Circulation. Genomic and Precision Medicine|September 16, 2020
Systematic Evaluation of KCNQ1 Variant Using ACMG/AMP Guidelines and Risk Stratification in Long QT Syndrome Type 1Asami Kashiwa, Takeshi Aiba, Hisaki Makimoto, et al.
JAMA Cardiology|February 14, 2019
Association of Genetic and Clinical Aspects of Congenital Long QT Syndrome With Life-Threatening Arrhythmias in Japanese PatientsWataru Shimizu, Hisaki Makimoto, Kenichiro Yamagata, et al.
Pageof 15